Biotech veteran Michael Gilman joins Arrakis full-time after $75M round
April 18, 2019 at 07:00 AM EDT
Waltham biotech startup Arrakis Therapeutics has grabbed the attention of Biogen veteran Michael Gilman full-time after raising a further $75 million.
